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The responses to 12-HETE in normal human skin have 
been investigated by means of intradermal and topical 
administration in 15 subjects. Intradermal infusion of 
12-HETE produced a neutrophil polymorphonuclear 
and mononuclear infiltrate in the dermis. Topical ad-
ministration resulted in a dose-related erythematous 
response to 200 ng-50 p.g. This was accompanied by a 
neutrophil and mononuclear dermal infiltrate at 6 and 
24 h after application. In addition, collections of neutro-
phils were present in the epidermis in 4 of 10 subjects 
biopsied at 6 h and in all patients biopsied 24 h after 
topical application. Intradermal and topical application 
of 9-hydroxyoctadecadienoic acid (9-HODD), a chemi-
callY similar but chemokinetically inactive substance, 
did not produce neutrophil infiltration of the epidermis, 
nor did the chemical irritant nonanoic acid. The results 
suggest that the cellular infiltrates produced in vivo in 
humans by 12-HETE are due to its chem?~tt~actant 
properties and are not the result of a nonspecific mflam-
matory response. 
The arachidonate li poxygenase product 12-S-hydroxy 
5,8,10,14-eicosatetraenoic ac id (12_-HE!E)_is formed via t he 
action of 12-lipoxygenase on arach1domc ac1d. 
In vitro 12-HETE was demonstrated to be chemotactic for 
polymorphonuclear leuk ocytes [1). Subsequently _it was shown 
that partially purified 12-HETE was chemotactic for eosino-
phils, with substantial activity for_ ne~trophil s_ and less activi ty 
for mononuclear cell s [2]. Further 111 v1tro stud1es demonstrated 
that 12-HETE was both chemokinetic and chemotactic for 
human eosinophil and neutrophil polymorphonuclear leuko-
cytes [3]. These observations were confirmed by Ford-Hutch-
·1150n et a l [ 4] and Palmer et al [5] who a lso demonstrated that ~ 11 vitro 12-HETE was approx imately 100 t imes less potent as 
a chemoattractant than leukotriene B •. 12-HETE has also been 
shown to stimulate huma n polymorphonuclear leukocyte ag-
gregation [6] . . . . . . . . 
The results of prevwus stud1es of the 111 v1vo properties of 
12-HETE have yielded conflicting results . 12-HETE injected 
i.p. into guinea pigs at doses of 4 and 8 p.g in 0.4 ml of Hanks' 
balanced sa lt solution induced an influx of eosinophils and 
neutrophi ls with peak leve ls at 30 min and 5 h , respectively. At 
5 h the neutrophils were t he predominant ce ll s [7) . The intra-
dermal injection of 1 p.g 12-HETE in 100 p.] Tris buffer, pH 
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7.5, into rabbit sk in enhanced t he infil tration of leukocytes, 
predominantly polymorphonuclear leukocytes, at 4 h [8). 
However, int radermal injection of 12-HETE into rabbit skin 
at doses up to 1 /lg/100 p.l Tris buffer did not sign ificantly 
increase t he leukocyte infiltration compared with that produced 
by cont rol injection of Tris buffer at t imes 1- 4 h after injection 
into rabbit skin [9). Furthermore, the introduction of 5 p.g 12-
HETE in 0.9% sodium chloride into the anterior chamber of 
the rabbit eye evoked no leukocyte infiltration in t he aqueous 
humor after 4 h [10] . To our knowledge t here have been no 
further investigations of t he in vivo effects of 12-HETE. 
Elevated levels of lipoxygenase products including 12-HETE 
have been found in psoriasis. Hammarstrom et al [11] found 
that the ratio of 12-HETE in t he involved compared to the 
uninvolved sk in of patients with psoriasis was approximately 
100. We have previously shown that 12-HETE is present in 
biologically active amounts in extracts of lesional psoriatic sk in 
[12- 15) and semiquantitative analysis by gas chromatography-
mass spectrometry showed a mean of approximately 1 11g 12-
HETE per 100 mg psoriatic scale [15]. Moreover, elevated levels 
of 12-HETE have been found in UV-irradiated normal human 
skin and anthralin-treated clinically normal skin of patients 
with chron ic plaque psoriasis [16). 
In view of the chemokinetic and chemotactic properties of 
12-HETE and its presence in psoriasis and inflamed skin, we 
considered that' an investigation of its in vivo properties in 
human skin was indicated. We have t herefore investigated t he 
in vivo effects of intradermal and topical administration of 12-
HETE in normal huma n skin. 
MATERIALS AND METHODS 
Chemically and biologically synthesized 12-HETE were used in the 
intradermal experiments. In t he investigation of the effects of topical 
administration of 12-HETE, chemically synthesized 12-HETE was 
used. 
Biologically synthesized 12-HETE was prepared by the method of 
Hammarstrom et al [11]. Arachidonic acid (150 11M) was incubated 
wit h washed human platelets and 12(8)-HETE was then isolated by 
si licic acid chromatography and straight-phase high-performance liquid 
chromatography (HPLC). 12(8) -HETE prepared in this manner was 
administered to the human subject from whom the washed platelet 
preparation was obtained. Chemically synthesized 12(R,S)-HETE was 
prepared by photooxidation of arachidonic acid [1.5]. Arachidonic acid 
(100 mg) in solution in methanol containing 0.01 % methylene blue was 
irradiated with 3X500-W incandescent bulbs (PF 318 P2/3) for 21/2 h. 
Oxygen was bubbled through the olution which was cooled below lO"C. 
The hydroperoxides so formed were reduced with sodium borohydride 
and the products subjected to preliminary purification by reversed-
phase gel partition chromatography using Lipidex 5000. The monohy-
droxy fatty acid fraction was subjected to straight-phase HPLC by 
which the positional isomers, including 12(R,S)-HETE, were isolated. 
9(R,S)-Hydroxyoctadecadienoic acid (9-HODD) was prepared by pho-
tolysis of linoleic acid (100 mg) in a manner identical to that by which 
12(R,S) -HETE was prepared from arachidonic acid [15]. Nonanoic 
acid (pelargonic acid, CH3(CH2)?COOH was obtained from the Sigma 
Chemica l Company, Poole, Dorset, U.K. Phosphate-buffered saline, 
0.04 M sodium phosphate, 0.154 M NaCI , pH 7.3 (PBS) was prepared 
under sterile condi t ions. 
In trade rmal injections were administered by a 25-gauge needle. 
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In tradermal in fus ions were administered by means of a portable bat-
te ry-operated MS26 syringe drive r (Graseby Dynamics Ltd., Watford, 
Herts., England). This a llowed the concurrent administration of solu-
tions from 2 separate insulin (1.0 ml) syringes attached to 27-gauge 
butte rfly cannulae. Biopsies were obtained by means of ste rile dispos-
able punch biopsies (3 mm) . Local anesthesia was achieved by 2% 
lignocaine without adrenaline. Biopsy specimens were fixed in formol 
sa line, and processed for light microscopy. Sections (4 J.tm) were stained 
by hematoxylin and eosin and viewed on a Wild microscope (lOX eye 
piece, 20X, 40X objectives). 
The overa ll histologic pattern of t he infil trate produced in response 
to 12- HETE was dete rmined at low magnification. In biopsies from 
sites of intradermal administration of 12-HETE a morphometric analy-
sis of the dermal infilt rate was performed as follows: the densest part 
of the dermal infiltrate was determined and 2 independent observers 
t hen counted the numbers of neut rophils, mononuclear cells, and 
vessels in each of 10 high-power fields (HPF) (400X magnification) of 
th is zone in each of 2 nonadjacent sections from each biopsy. Sections 
from test vs control sites were examined blind by the observers. The 
results were expressed as t he number of cells or vessels per HPF. The 
significance of t he differences in numbers of cells in sections from test 
and cont rol sites was determined by paired t-tests. 
Analys is of regression was employed to determine whether the in -
crease in number of inflammatory cells was quantitatively related to 
the vascula rity of t he field. Analyses of variance were performed to 
establish whether t he nature of the control substance quantitatively 
a ffected t he infilt rate. 
In biopsies obtained from sites after topica l administrat ion of 12-
HETE, a morphometric analysis of t he epidermal infiltrate was per-
formed. Morphometric ana lysis of t he neutrophil epidermal infiltrate 
was achieved by 2 independent observers. Cells were counted in adja-
cent HPF a long the full length of the epidermis of 2 nonadjacent 
sections from each biopsy. In order to allow for variation in the length 
of t he histologic sections, the results were expressed as the number of 
neutrophils per 10 HPF. 
S ubjects 
All subjects were healt hy adults with normal skin. 
Intradermal Administration 
Five and forty micrograms of chemically synthesized 12-HETE were 
injected intradermally in to the forearm skin of 3 subjects. The site was 
observed for 8 h and then biops ied. 
Biologically synt hesized 12-HETE was administered by intradermal 
infusion with PBS as control to 2 patients. Chemically synthesized 12-
HETE was administered to 2 patients with PBS as a control and to a 
further 2 patients with 9-HODD as control. 9-HODD was chosen as a 
contro l because of its chemical simila ri ty to 12-HETE and its lack of 
leukocyte chemokinetic activity in the agarose microdroplet assay 
which we employ to determine biologic activity [15] . Solutions of 12-
HETE and 9- HODD (both 0.39 mM) were made up in PBS. These and 
PBS a lone were infused at a rate of 40 J.tl / h for 8 h, at t he end of which 
the inflammatory response was observed. The total dose of 12-HETE 
was 40 1-<g. Biopsies of test and control sites were then performed. The 
inflammatory infiltrates were characterized histologically and the in -
t rade rmal infiltrate subjected to morphometric analys is as above. 
Topical Administration 
Chemically sythesized 12-HETE was administered topically in doses 
of 200 ng-50 J.lg in 5 J.tl ethanol to a 0.25-cm2 a rea of the skin of the 
ventra l surface of t he forearm. The ethanol was evaporated and the 
res idue occluded for 6 h (n = 15). The erythematous response was 
observed for 48 h and repeated measurements at different t ime interva ls 
of the 2 largest diameters of erythema to the nearest 1 mm were made 
by a transparent rule at each app lication site in order to establish a 
dose response. 12-HETE (20 J.tg) in 5 J.tl ethanol was t hen applied to 
the ventral surface of the skin of the forearm of 15 subjects. Biopsies 
were taken at either 6- 8 h (10 subjects) or 24 h (5 subjects) . An 
equimolar solution of 9-HODD in 5 J.tl ethanol a nd undiluted nonanoic 
acid were simila rly applied to the forearm skin as controls (3 and 2 
subjects, respective ly). In addition, a 40% solution of nonanoic acid in 
propan -2-ol was applied to t he ventral surface of the forearm under 
occlusion for 24 h and then biopsied. Biopsies of control s ites were 
performed 24 h afte r topica l applications. Nonanoic ac id was chosen 
as an addit iona l control because of its chemical irritant properties 
[16]. 
RESULTS 
Intradermal Administration by Injection 
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The intradermal injection of 12-HETE (5 and 40 J<g) pro-
duced no visible inflammatory response after 8 h observation 
and histology of the injection sites at 8 h revealed on ly a sparse 
perivascular infiltrate in the dermis. 
Intradermal Administration by Infusion 
Erythema of approximately equ ivalent extent was evident at 
both test and control infusion sites at the completion of the 
infusion. Histology of the sites of infusion of both biologically 
and chemically synthesized 12-HETE revealed an infiltrate 
around vessels and randomly distributed in the dermis, whereas 
histology of PBS and 9-HODD infusion sites revealed only a 
slight increase in perivascular inflammatory cells. The infiltrate 
in the 12-HETE infusion sites consisted of neutrophil poly-
morphonuclear leukocytes and mononuclear cells (Fig 1). Mor-
phometric analysis revealed a mean increase of 12.2 neutrophils 
and 6.5 mononuclear cells per HPF (for original data see Table 
I) in 12-HETE infusion sites compared with control infusion 
sites. Paired t-tests revealed these differences to be significant 
(p = 0.03) in each case. Analysis of regression revealed no 
evidence of a correlation between the numbers of cells of each 
type and the number of vessels per HPF (Table I) , thus indi -
cating that the density of the cellular infiltrate was not merely 
a ref1ection of the vascularity of the field. 
There was no evidence of a quantitative or qualitative differ-
ence between the numbers of cells present in the infiltrates 
produced by biologically or chemically synthesized 12-HETE 
when these were compared in relation to each other with PBS 
as control infusion by analysis of variance. Analysis of variance 
showed t hat the increase in population density of infiltrating 
cells did not significantly differ irrespective of whether PBS or 
9-HODD was used as a control. 
Topical Administration 
A dose- related erythematous response was obtained when 
200 ng- 50 Jig 12-HETE was applied to forearm skin (Table II). 
F1c 1. Photomicrograph of 12-HETE infusion site showing neutro-
phil polymorphonuclear leukocytes and mononuclear cell infiltrates 
around vessels and randomly distributed in t he dermis. 
June 1985 HUMAN CUTANEOUS RESPONSES TO 12-HETE 539 
TABLE I. Mononuclear and neutrophil cell and blood vessel counts in skin infused with 12-HETE a.nd control substance 
Number of Number of Number of Number of Number of Number of Subject Active Control neutrophils mononuclear ce lls vesse ls neutrophils mononuclear cells vessels 
number substance substance per HPF per HPF per HPF per HPF per HPF per HPF 
1 Biologically synthesized 17.3 10.1 1.7 PBS 0.8 0.7 1.0 
12-HETE 
2 Biologically synthesized 16.5 4.9 0.9 PBS 1.2 0.9 0.9 
12-HETE 
3 Chemically synthesized 16.8 9.2 1.0 PBS 0.5 0.2 0.5 
12-HETE 
4 Chemically synthesized 15.8 4.9 0.6 PBS 0.7 0.6 1.2 
12-HETE 
5 Chemically synthesized 6.8 9.7 0.5 9-HODD 0.4 0.6 1.1 
12-HETE 
6 Chemically synthesized 6.3 5.4 1.2 9-HODD 0.8 2.4 0.9 
12-HETE 
M ea n numbers of ce lls and vessels per HPF (n = 10) present in the infi lt rates at t he test and control infusion sites at the completion of 8- h 
infus i o ns. 
TABLE II. Area of erythema (mm 2) after topical application. of 12-HETE 
Area of erythema at 6 h Area of erythema at 24 h 
Subject J.lg dose of 12-HETE ll g dose of 12-HETE 
2 5 10 20 50 2 5 10 20 50 
33.18 33.48 44.18 63.62 70.88 9.62 19.63 38.48 44.18 70.88 
2 12.57 19.63 23.76 33.18 78.54 7.07 9.62 9.62 15.90 19.63 
3 19.63 12.57 28.27 19.63 23.76 0.00 0.00 0.00 0.00 0.00 
4 19.63 63.62 56.74 78.54 95.03 56.74 44.18 28.27 23.76 VFDE 
5 FE VFE VFE 19.63 28.27 0.00 0.00 0.00 0.00 28.27 
6 19.63 23.76 38.48 70.88 70.88 7.07 7.07 15.90 19.63 38.48 
Mean 14.16 22.38 25.49 35.77 49.41 12.23 12.23 12.73 14.78 19.79 
± 
SEM 12.84 24 .76 22 .96 29.70 37.25 22.19 16.73 16.73 16.46 27.27 
Key: FE = faint erythema; VFE = very faint erythema; VFDE = very fain t diffuse erythema. 
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FIG 2. Photomicrograph of histologic appearances 6 h after topica l 
application of 12-HETE, showing a neutrophil and mononuclea r ce ll 
infiltrate at the dermal-epidermal junction and discrete collections of 
neutrophils in the epidermis. 
No pustules were see n but in 3 subjects the erythema was 
accompanied by edema. At s ites of application of doses of 20 
and 50 !Lg, erythema lasted for 15-24 h in the majority of 
s ubjects. There was, however, considerable intersubject varia-
tion in t he magnitude of t he erythematous response at 24 h 
F IG 3. Photomicrograph of histologic appearances in a biopsy ta ken 
24 h after topica l application of 12- HETE, showing discrete collections 
of neutrophils in t he epidermis. 
(Table II) . No visible reaction was seen after 9-HODD appli -
cation at 6 and 24 h. Following the application of undiluted 
nonanoic ac id, palpable erythema without vesiculation or pus -
tu lation was seen at 6 and 24 h. Nonpalpable erythema was 
presen t after 40% nonanoic acid solution was applied to the 
skin under occlusion for 24 h. 
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FIG 4. Histologic appearances after topical application of undiluted 
nonanoic acid showing necrolytic changes in the malpighian layer of 
the epidermis. 
In all 10 biopsies taken 6- 8 h after the topical application of 
20 /--1-g 12-HETE, dermal neutrophil and mononuclear cell infil -
trates were seen. These were of maximal intensity a round the 
upper dermal vessels, and in places the in filtrate impinged on 
t he dermal-epidermal junction. In 4 of the 10 biopsies discrete 
collections of neutrop hils could also be seen in t he epidermis 
(Fig 2). 
In all 5 biops ies taken 24 h after t he application of 12-HETE 
there was a neutrophil and mononuclear cell infiltrate in t he 
dermis. T his was accompanied by an in traepide rmal neutrophil 
infiltrate, often occurring in the form of discrete accumulations 
of neutrophils in a subcorneal position (Fig 3) . 
There was considerable intersubject variation in the 
populat ion density of the neutrophils in t he ep idermis (73.9 ± 
21.8) . 
There was no increase in t he number of neutrophil or mono-
nuc lea r cells in the epidermis in histologic sections from biop-
sies performed 24 h after topical app lication of 9-HODD but a 
sparse mono nuclear ce ll dermal infilt rate was observed. The 
most striking feature of the histologic appearances resul t ing 
from the topical application of undiluted nonanoic ac id was a 
marked necrolytic change affecting the malpighian layer of the 
epiderm is. T here was only minimal accompanying spongiosis 
and a sparse mononuclear cell infil t rate in t he dermis (Fig 4) . 
Histology of biopsies from sites to which a 40% solut ion of 
nonanoic acid had been applied under occlusion for 24 h showed 
marked ep idermal nec rosis and spongiosis and a sparse mixed 
predominantly perivascular mononuclear infiltrate in the der-
mis. 
DISCUSSION 
These results indicate that biologically and chemically syn-
thesized 12-HETE are capable of elicit ing a neutrophil poly-
morphonuclear and mononuclear leu kocyte infiltrate when ad-
ministered by intradermal infusion into normal human skin . 
The insign ificant responses to infusions of an equimolar con-
centration of 9-HODD and to PBS alone indicated that these 
effects were not merely t he resul t of t he presence of nonspecific 
chemical irritants in t he skin or t he result of t he infusion 
needle acting as a physical irri tant to t he skin. 
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Interestingly, in cont rast to previous reports of the in vitro 
and in vivo effects of 12-HETE (1 ,2,3,5 ) indicating t hat 12-
HETE was a chemoattractant for eosinophils, no evidence of 
eosinophil accumulation was seen in any of t he biopsies ob-
tained after administration of 12-HETE to human sk in. Pos-
sible explanations for t his find ing a re species differences in 
response to 12-HETE or an earlier accu mulation and subse-
quent disappearance of eosinophils from the infil trates by 6 h . 
The fai lure of the linoleic acid derivative 9-HODD to produce 
an inflammatory response suggested t hat the intradermal and 
topical administration of 12-HETE could not be explained on 
t he basis of a chemical irritant effect produced by the presence 
of a fatty acid derivative in t he skin. Moreover, the neutrophil 
infil t rates resul ting from the administration of topically applied 
12-HETE were not ev iden t in response to t he topical applica-
t ion of the primary irri tant nonanoic acid [17]. This suggests 
t hat t.he observed inflammatory changes resu lt from t he che-
moattractant properties of 12-HETE and not from any role it 
might have as a chemical irri tant. 
Further evidence that the clinical and histologic responses 
observed after topical application of 12-HETE were not those 
of a chemical irri tant comes from the study of Bji:irnberg [18], 
who characterized the cl in ical and histo logic changes 24 h after 
application of primary irritants to the skin. Only in severe 
irritant reactions characterized clinically by erythema, infiltra-
t ion, and pustulat ion were discrete collections of polymorpho-
nuclear leukocytes seen in t he epidermis and t hen t hese were 
always accompanied by lymp hocytes and spongiosis. Spongiosis 
was evident also in clinically less severe irritant reactions which 
were not characterized by leukocytic infilt ration of the ep ider-
mis. Spongiosis was never observed in biopsies from sites 
fo llowing administration of 12-HETE. 
The conflicting results of prev ious in vivo studies on the 
effects of 12-HETE can, perhaps, on careful review of the 
literature, be expla ined by the use of different amounts of 12-
HETE and by the differences in t ime between in vivo admin-
istration and subsequent sampling of gu inea pig peri toneal fluid 
[7) and rabbit skin [8,9) and aqueous humor (10] . T he results 
of t he experiments reported here indicate that 12-HETE is 
capable of eliciting a neutrophil and mononuclear cell infiltrate 
in human skin and that the infiltrates resul t from specific 
chemoattractant properties of 12-HETE. In view of the pres-
ence of 12-HETE in elevated amounts in psoriasis and experi-
mentally produced inflammatory reactions, it may well be 
relevant to the pathogenesis of the neutrophil infilt rate in 
psoriasis and have an in vivo role as an inflammatory mediator 
in humans. 
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